The Sage Group peripheral arterial and venous disease

REPORTS
(Sorted by Topic)

ACUTE LIMB ISCHEMIA

Acute Limb Ischemia (ALI)
A Market of Multiple Therapies and Multiple Procedures
Additional Information

CODING AND REIMBURSEMENT

Peripheral Arterial Disease
Coding and Reimbursement 2008
Additional Information

CRITICAL LIMB ISCHEMIA

India Peripheral Arterial Disease, Thromboangiitis Obliterans
& Critical Limb Ischemia Epidemiology and Markets
Additional Information

Critical Limb Ischemia
Volume II
Western Europe Epidemiology
Additional Information

Critical Limb Ischemia
Volume I
United States Epidemiology
Additional Information

INTERMITTENT CLAUDICATION

Intermittent Claudication Europe. A Country-Specific Market Analysis of Oral IC Therapies and A Population-Based Analysis of the Potential Market 2007-2020
Additional Information

PERIPHERAL ARTERIAL DISEASE

Peripheral Arterial Disease - New Pharmaceutical Therapies to Treat Intermittent Claudication Symptoms, Prevent Ischemic Events and to Induce Angiogenesis
Additional Information

Volume I
Peripheral Arterial Disease
Underestimated, Underdiagnosed and Undertreated
A Significant Opportunity for Drug Therapies
Additional Information

Volume II
Peripheral Arterial Disease
A Significant Opportunity for Interventional Therapies
Additional Information

THERAPIES—PHARMACEUTICAL

Peripheral Arterial Disease - New Pharmaceutical Therapies to Treat Intermittent Claudication Symptoms, Prevent Ischemic Events and to Induce Angiogenesis
Additional Information

Intermittent Claudication Europe. A Country-Specific Market Analysis of Oral IC Therapies and A Population-Based Analysis of the Potential Market 2007-2020
Additional Information

Peripheral Arterial Disease (PAD) Interventional Market Analysis 
Based on Potential Treatment with Perioperative Oral Antiplatelet Therapy       
Additional Information

Volume I
Peripheral Arterial Disease
Underestimated, Underdiagnosed and Undertreated
A Significant Opportunity for Drug Therapies
Additional Information

THERAPIES—REVASCULARIZATION

Peripheral Arterial Disease (PAD) Interventional Market Analysis 
Primary and Provisional Stenting
Additional Information

Peripheral Arterial Disease (PAD) Interventional Market Analysis 
Based on Treatment with Angioplasty or Atherectomy
Additional Information

Peripheral Arterial Disease (PAD) Interventional Market Analysis 
Based on Potential Treatment with Perioperative Oral Antiplatelet Therapy       
Additional Information

Volume II
Peripheral Arterial Disease
A Significant Opportunity for Interventional Therapies
Additional Information

NEW REPORT

Peripheral Arterial Disease: Interventional Market Analysis Based on Treatment with Angioplasty or Atherectomy

Additional Information

According to THE SAGE GROUP, in 2006 approximately 550,000 inpatient procedures were performed in the lower limbs. Over 40% were endovascular procedures (angioplasty, atherectomy and primary stenting) while surgery accounted for slightly more than 30%.

 
.